AAPL297.49+3.19 (+1.08%) ▲|ABBV234.67-0.10 (-0.04%) ▼|ABT91.05+0.52 (+0.57%) ▲|ACN129.20+2.19 (+1.72%) ▲|ADBE198.64+1.21 (+0.61%) ▲|AMAT588.23+2.35 (+0.40%) ▲|AMD518.61-1.24 (-0.24%) ▼|AMGN351.39+4.38 (+1.26%) ▲|AMT175.05-4.33 (-2.41%) ▼|AMZN239.89+5.78 (+2.47%) ▲|AVGO384.07+3.92 (+1.03%) ▲|AXP342.76+4.98 (+1.47%) ▲|BA220.97+4.26 (+1.97%) ▲|BAC57.53-0.39 (-0.66%) ▼|BKNG182.11+13.17 (+7.80%) ▲|BLK982.52-32.81 (-3.23%) ▼|BMY55.09-0.44 (-0.79%) ▼|BNY145.28-2.01 (-1.36%) ▼|BRK-B497.07+4.26 (+0.86%) ▲|C143.40-1.57 (-1.08%) ▼|CAT1,000.35+16.11 (+1.64%) ▲|CL92.99+1.56 (+1.71%) ▲|CMCSA22.59-0.22 (-0.94%) ▼|COF201.81+4.00 (+2.02%) ▲|COP106.94-3.04 (-2.76%) ▼|COST961.11+3.43 (+0.36%) ▲|CRM154.33+0.91 (+0.59%) ▲|CSCO120.51-0.64 (-0.53%) ▼|CVS101.46-0.12 (-0.11%) ▼|CVX171.56-4.42 (-2.51%) ▼|DE609.73+17.79 (+3.01%) ▲|DHR187.97+9.00 (+5.03%) ▲|DIS102.29-1.24 (-1.20%) ▼|DUK125.18+0.13 (+0.10%) ▲|EMR142.20-0.94 (-0.66%) ▼|FDX313.03-4.21 (-1.33%) ▼|GD346.28-4.06 (-1.16%) ▼|GE367.55+11.08 (+3.11%) ▲|GEV1,063.92+28.94 (+2.80%) ▲|GILD125.47+0.42 (+0.34%) ▲|GM79.81+0.86 (+1.09%) ▲|GOOG347.89+1.81 (+0.52%) ▲|GOOGL348.75+2.66 (+0.77%) ▲|GS1,081.98-12.46 (-1.14%) ▼|HD340.26+15.81 (+4.87%) ▲|HON227.06+4.69 (+2.11%) ▲|IBM262.50-2.44 (-0.92%) ▼|INTC132.90+0.62 (+0.47%) ▲|INTU268.42+10.37 (+4.02%) ▲|ISRG401.83-1.35 (-0.33%) ▼|JNJ240.48+1.40 (+0.59%) ▲|JPM333.09-1.06 (-0.32%) ▼|KO81.24+0.93 (+1.15%) ▲|LIN521.77+9.51 (+1.86%) ▲|LLY1,109.80+2.72 (+0.25%) ▲|LMT493.50-10.17 (-2.02%) ▼|LOW220.88+7.34 (+3.44%) ▲|LRCX368.81-2.52 (-0.68%) ▼|MA493.69+5.62 (+1.15%) ▲|MCD274.21+2.55 (+0.94%) ▲|MDLZ62.15+1.09 (+1.79%) ▲|MDT80.65+0.02 (+0.02%) ▲|META560.77-1.43 (-0.25%) ▼|MMM167.73+5.89 (+3.64%) ▲|MO72.05+0.44 (+0.61%) ▲|MRK120.85+1.25 (+1.04%) ▲|MS221.35-4.69 (-2.07%) ▼|MSFT372.37-1.58 (-0.42%) ▼|MU1,037.63-14.15 (-1.34%) ▼|NEE86.79+0.36 (+0.41%) ▲|NFLX71.73-1.10 (-1.50%) ▼|NKE41.99-0.40 (-0.93%) ▼|NOW94.53-1.41 (-1.47%) ▼|NVDA199.69-0.32 (-0.16%) ▼|ORCL157.45-7.71 (-4.67%) ▼|PEP143.17+1.12 (+0.79%) ▲|PFE24.15-0.58 (-2.33%) ▼|PG153.09+2.23 (+1.47%) ▲|PLTR113.22-3.48 (-2.98%) ▼|PM178.59-0.10 (-0.06%) ▼|QCOM196.22-7.92 (-3.88%) ▼|RTX185.84-0.55 (-0.30%) ▼|SBUX103.92+2.87 (+2.84%) ▲|SCHW91.38-1.79 (-1.92%) ▼|SO94.74-0.20 (-0.21%) ▼|SPG218.90+2.16 (+1.00%) ▲|T22.41-0.41 (-1.78%) ▼|TMO489.11+19.76 (+4.21%) ▲|TMUS182.76-1.81 (-0.98%) ▼|TSLA378.32-3.29 (-0.86%) ▼|TXN303.86-0.50 (-0.16%) ▼|UBER74.45+4.78 (+6.86%) ▲|UNH406.37-2.89 (-0.70%) ▼|UNP260.55+1.94 (+0.75%) ▲|UPS105.24-0.59 (-0.56%) ▼|USB60.02-0.03 (-0.05%) ▼|V331.70+3.22 (+0.98%) ▲|VZ45.58-1.16 (-2.47%) ▼|WFC83.89-0.24 (-0.29%) ▼|WMT119.52+0.10 (+0.08%) ▲|XOM136.44-3.29 (-2.35%) ▼|AAPL297.49+3.19 (+1.08%) ▲|ABBV234.67-0.10 (-0.04%) ▼|ABT91.05+0.52 (+0.57%) ▲|ACN129.20+2.19 (+1.72%) ▲|ADBE198.64+1.21 (+0.61%) ▲|AMAT588.23+2.35 (+0.40%) ▲|AMD518.61-1.24 (-0.24%) ▼|AMGN351.39+4.38 (+1.26%) ▲|AMT175.05-4.33 (-2.41%) ▼|AMZN239.89+5.78 (+2.47%) ▲|AVGO384.07+3.92 (+1.03%) ▲|AXP342.76+4.98 (+1.47%) ▲|BA220.97+4.26 (+1.97%) ▲|BAC57.53-0.39 (-0.66%) ▼|BKNG182.11+13.17 (+7.80%) ▲|BLK982.52-32.81 (-3.23%) ▼|BMY55.09-0.44 (-0.79%) ▼|BNY145.28-2.01 (-1.36%) ▼|BRK-B497.07+4.26 (+0.86%) ▲|C143.40-1.57 (-1.08%) ▼|CAT1,000.35+16.11 (+1.64%) ▲|CL92.99+1.56 (+1.71%) ▲|CMCSA22.59-0.22 (-0.94%) ▼|COF201.81+4.00 (+2.02%) ▲|COP106.94-3.04 (-2.76%) ▼|COST961.11+3.43 (+0.36%) ▲|CRM154.33+0.91 (+0.59%) ▲|CSCO120.51-0.64 (-0.53%) ▼|CVS101.46-0.12 (-0.11%) ▼|CVX171.56-4.42 (-2.51%) ▼|DE609.73+17.79 (+3.01%) ▲|DHR187.97+9.00 (+5.03%) ▲|DIS102.29-1.24 (-1.20%) ▼|DUK125.18+0.13 (+0.10%) ▲|EMR142.20-0.94 (-0.66%) ▼|FDX313.03-4.21 (-1.33%) ▼|GD346.28-4.06 (-1.16%) ▼|GE367.55+11.08 (+3.11%) ▲|GEV1,063.92+28.94 (+2.80%) ▲|GILD125.47+0.42 (+0.34%) ▲|GM79.81+0.86 (+1.09%) ▲|GOOG347.89+1.81 (+0.52%) ▲|GOOGL348.75+2.66 (+0.77%) ▲|GS1,081.98-12.46 (-1.14%) ▼|HD340.26+15.81 (+4.87%) ▲|HON227.06+4.69 (+2.11%) ▲|IBM262.50-2.44 (-0.92%) ▼|INTC132.90+0.62 (+0.47%) ▲|INTU268.42+10.37 (+4.02%) ▲|ISRG401.83-1.35 (-0.33%) ▼|JNJ240.48+1.40 (+0.59%) ▲|JPM333.09-1.06 (-0.32%) ▼|KO81.24+0.93 (+1.15%) ▲|LIN521.77+9.51 (+1.86%) ▲|LLY1,109.80+2.72 (+0.25%) ▲|LMT493.50-10.17 (-2.02%) ▼|LOW220.88+7.34 (+3.44%) ▲|LRCX368.81-2.52 (-0.68%) ▼|MA493.69+5.62 (+1.15%) ▲|MCD274.21+2.55 (+0.94%) ▲|MDLZ62.15+1.09 (+1.79%) ▲|MDT80.65+0.02 (+0.02%) ▲|META560.77-1.43 (-0.25%) ▼|MMM167.73+5.89 (+3.64%) ▲|MO72.05+0.44 (+0.61%) ▲|MRK120.85+1.25 (+1.04%) ▲|MS221.35-4.69 (-2.07%) ▼|MSFT372.37-1.58 (-0.42%) ▼|MU1,037.63-14.15 (-1.34%) ▼|NEE86.79+0.36 (+0.41%) ▲|NFLX71.73-1.10 (-1.50%) ▼|NKE41.99-0.40 (-0.93%) ▼|NOW94.53-1.41 (-1.47%) ▼|NVDA199.69-0.32 (-0.16%) ▼|ORCL157.45-7.71 (-4.67%) ▼|PEP143.17+1.12 (+0.79%) ▲|PFE24.15-0.58 (-2.33%) ▼|PG153.09+2.23 (+1.47%) ▲|PLTR113.22-3.48 (-2.98%) ▼|PM178.59-0.10 (-0.06%) ▼|QCOM196.22-7.92 (-3.88%) ▼|RTX185.84-0.55 (-0.30%) ▼|SBUX103.92+2.87 (+2.84%) ▲|SCHW91.38-1.79 (-1.92%) ▼|SO94.74-0.20 (-0.21%) ▼|SPG218.90+2.16 (+1.00%) ▲|T22.41-0.41 (-1.78%) ▼|TMO489.11+19.76 (+4.21%) ▲|TMUS182.76-1.81 (-0.98%) ▼|TSLA378.32-3.29 (-0.86%) ▼|TXN303.86-0.50 (-0.16%) ▼|UBER74.45+4.78 (+6.86%) ▲|UNH406.37-2.89 (-0.70%) ▼|UNP260.55+1.94 (+0.75%) ▲|UPS105.24-0.59 (-0.56%) ▼|USB60.02-0.03 (-0.05%) ▼|V331.70+3.22 (+0.98%) ▲|VZ45.58-1.16 (-2.47%) ▼|WFC83.89-0.24 (-0.29%) ▼|WMT119.52+0.10 (+0.08%) ▲|XOM136.44-3.29 (-2.35%) ▼|
24.7 C
New York
Wednesday, June 24, 2026

Tag: press release

newssourceFORcompanyinformationcontent1marketreleases

Ambrosia Biosciences Announces Preclinical Data Supporting Differentiated Profile of AMB-702, its Novel Small Molecule GLP-1 Receptor Agonist Development Candidate

AMB-702 demonstrates superior target coverage and efficacy in lean non-human primates The dataset was shared as part of a poster presentation at the American Diabetes...

Hengrui Pharma and Kailera Therapeutics Present Ribupatide Clinical Data at ADA 2026

Hengrui Pharma and Kailera Therapeutics Present Ribupatide Clinical Data at ADA 2026

Biomea Fusion Presents New Clinical and Translational Data for Icovamenib at the American Diabetes Association (“ADA”) 86th Scientific Sessions and Announces Expansion of Ongoing...

•Translational data presented at ADA demonstrate icovamenib’s potential to promote muscle preservation and fat reduction, supporting its broader therapeutic utility in obesity and diabetes, including as a complementary therapy alongside GLP-1 receptor agonists to enhance metabolic health outcomes 
• Clinical data presented at ADA from COVALENT-112 show improvements in HbA1c and C-peptide in type 1 diabetes patients treated with icovamenib, with no evidence of immune activation, and inflammatory markers stable or reduced
• Additionally, the Company expanded its Phase I BMF-650 study to evaluate a rapid one-step titration and enhanced weight loss potential with its oral GLP-1 receptor agonist

Power Metallic Mines Files Amended LIFE Offering Document to include Quebec as an Offering Jurisdiction for previously announced Brokered LIFE Offering for Gross Proceeds...

/THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/TORONTO, June 5, 2026 /CNW/ - Power...

AURION OBTAINS SECURITYHOLDER APPROVAL FOR PLAN OF ARRANGEMENT WITH AGNICO EAGLE MINES LIMITED

ST. JOHN'S, NL, June 5, 2026 /CNW/ - Aurion Resources Ltd. (TSXV: AU) (OTCQX: AIRRF) ("Aurion") is pleased to announce that, at its special meeting (the...

Vireo Growth Inc. Completes Acquisition of Bridgewell Agribusiness LLC and Plans to Acquire Dispensaries in Nevada and Maryland

Vireo Growth Inc. completes acquisition of Bridgewell Agribusiness LLC and plans to acquire dispensaries in Nevada and Maryland.

Quantinuum Announces Closing of Upsized Initial Public Offering

BROOMFIELD, Colo., June 6, 2026 /PRNewswire/ -- Quantinuum Inc. (Nasdaq: QNT) ("Quantinuum") today announced the closing of its upsized initial public offering of 28,000,000...

Quantinuum Announces Closing of Upsized Initial Public Offering

BROOMFIELD, Colo., June 5, 2026 /PRNewswire/ -- Quantinuum Inc. (Nasdaq: QNT) ("Quantinuum") today announced the closing of its upsized initial public offering of 28,000,000...

Premier Health of America Announces Grant of Management Cease Trade Order

MONTREAL, June 05, 2026 (GLOBE NEWSWIRE) -- PREMIER HEALTH OF AMERICA INC. (TSX-V: PHA) (“Premier Health”, or the “Company”) announces that, further to its press release dated June 2, 2026, the Autorité des marchés financiers, as the Company’s principal regulator, has granted a management cease trade order (the “MCTO”) under National Policy 12-203 – Management Cease Trade Orders.

BIRKS GROUP ANNOUNCES THE CLOSING OF A NEW TERM LOAN FACILITY WITH GORDON BROTHERS REPLACING ITS FORMER TERM LOAN FACILITY AND THE EXTENSION OF...

All figures presented herein are in Canadian dollars, unless indicated otherwise.MONTREAL, June 5, 2026 /CNW/ - Birks Group Inc. ("Birks Group" or the "Company")...

Caliber Announces CFO Transition

SCOTTSDALE, Ariz., June 05, 2026 (GLOBE NEWSWIRE) -- Caliber (Nasdaq: CWD), a diversified real estate and digital asset management platform, today announced that Jade Leung will step down as Chief Financial Officer to pursue a new opportunity, capping an eleven-year tenure during which he built Caliber’s finance organization and helped lead the Company through its initial public offering. Mr. Leung will support an orderly transition. The change is not the result of any disagreement with the Company on any matter relating to its operations, accounting policies, practices, or financial reporting. Caliber reaffirms the full-year 2026 guidance issued on its first quarter 2026 earnings call, and the transition does not affect the Company’s strategy or financial outlook.

TKROBOTS Launches AI Quant Trading Platform With Free Trial Access for New Users

TKROBOTS introduces an AI-powered crypto quantitative trading platform with automated execution, wallet management, daily settlement records, and free trial access for new users. 
TKROBOTS introduces an AI-powered crypto quantitative trading platform with automated execution, wallet management, daily settlement records, and free trial access for new users.

Quantinuum Announces Closing of Upsized Initial Public Offering

BROOMFIELD, Colo., June 5, 2026 /CNW/ -- Quantinuum Inc. (Nasdaq: QNT) ("Quantinuum") today announced the closing of its upsized initial public offering of 28,000,000...

New data from Phase 2 ZUPREME-1 trial at the American Diabetes Association 2026 Scientific Sessions further support potential of petrelintide to redefine the weight...

Press release – No. 13 / 2026 

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsPress release

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers